Active Ingredient History
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. ULTIVA is a µ-opioid agonist with rapid onset and peak effect, and short duration of action. The µ-opioid activity of ULTIVA is antagonized by opioid antagonists such as naloxone. ULTIVA is indicated for IV administration: 1. As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. 2. For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. 3. As an analgesic component of monitored anesthesia care in adult patients. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Pain (approved 1996)
Abortion, Induced (Phase 3)
Acute Lung Injury (Phase 4)
Acute Pain (Phase 4)
Adrenal Gland Diseases (Phase 4)
Airway Extubation (Phase 4)
Analgesia (Phase 4)
Analgesics, Opioid (Phase 4)
Anesthesia (Phase 4)
Anesthesia, Conduction (Phase 4)
Anesthesia, Endotracheal (Phase 4)
Anesthesia, General (Phase 4)
Anesthesia, Intravenous (Phase 4)
Anesthesia, Local (Phase 4)
Anesthesia Recovery Period (Phase 4)
Anesthetics (Phase 4)
Anesthetics, Intravenous (Phase 4)
Anxiety (Phase 4)
Aortic Diseases (Phase 4)
Aortic Valve Stenosis (Phase 4)
Arthropathy, Neurogenic (Phase 4)
Asthma (Phase 4)
Autonomic Nervous System Diseases (Phase 4)
Axis, Cervical Vertebra (Phase 4)
Bariatric Surgery (Phase 4)
Biliary Tract Diseases (Phase 4)
Bradycardia (Phase 3)
Brain Injuries (Phase 4)
Breast Diseases (Phase 3)
Breech Presentation (Phase 3)
Bronchial Diseases (Phase 4)
Bronchoscopy (Phase 4)
Bunion (Phase 2)
Burns (Phase 4)
Cardiopulmonary Bypass (Phase 4)
Carotid Stenosis (Phase 4)
Cervix Uteri (Phase 4)
Cesarean Section (Phase 3)
Child (Phase 3)
Child Development (Phase 3)
Cholecystitis, Acute (Phase 4)
Chronic Pain (Phase 4)
Cognition Disorders (Phase 4)
Colonoscopy (Phase 4)
Conscious Sedation (Phase 4)
Coronary Artery Disease (Phase 4)
Cough (Phase 4)
Craniotomy (Phase 4)
Critical Illness (Phase 4)
Delayed Emergence from Anesthesia (Phase 4)
Delirium (Phase 4)
Drug Interactions (Phase 4)
Drug Misuse (Phase 4)
Drug Overdose (Phase 1/Phase 2)
Drugs, Investigational (Phase 1/Phase 2)
Electroconvulsive Therapy (Phase 4)
Electroencephalography (Phase 4)
Epigenomics (Phase 4)
Esophageal Neoplasms (Phase 4)
Fentanyl (Phase 4)
Fetus (Phase 3)
Fibroins (Phase 4)
Fractures, Closed (Phase 4)
General Surgery (Phase 4)
Goiter, Nodular (Phase 4)
Healthy Volunteers (Phase 4)
Heart Diseases (Phase 4)
Heart Failure, Diastolic (Phase 4)
Hematologic Diseases (Phase 1/Phase 2)
Hemodynamics (Phase 4)
Hernia (Phase 4)
Hyperalgesia (Phase 4)
Hyperglycemia (Phase 4)
Hypertension (Phase 4)
Hypertension, Pregnancy-Induced (Phase 4)
Hypotension (Phase 3)
Hypothermia (Phase 4)
Hysterectomy (Phase 2)
Hysterectomy, Vaginal (Phase 3)
Hysteroscopy (Phase 4)
Infant, Premature (Phase 1/Phase 2)
Infusions, Intravenous (Phase 4)
Inhalation (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 4)
Intubation (Phase 4)
Intubation, Intratracheal (Phase 4)
Ketamine (Phase 2)
Kidney Calculi (Phase 4)
Labor, Obstetric (Phase 4)
Labor Pain (Phase 4)
Lung Diseases (Phase 4)
Lung Neoplasms (Phase 4)
Magnetic Resonance Imaging (Phase 3)
Magnetic Resonance Spectroscopy (Phase 4)
Malocclusion, Angle Class III (Phase 4)
Mandibular Diseases (Phase 4)
Morphine (Phase 2)
Muscle Relaxation (Phase 4)
Myocardial Ischemia (Phase 4)
Myocardial Reperfusion Injury (Phase 4)
Myoclonus (Phase 4)
Nasal Polyps (Phase 4)
Nasal Septal Perforation (Phase 4)
Neoplasms (Phase 3)
Neuralgia, Postherpetic (Phase 3)
Neuromuscular Blockade (Phase 4)
Neurosurgery (Phase 3)
Nitric Oxide (Phase 3)
Nociceptive Pain (Phase 1/Phase 2)
Obesity (Phase 4)
Obesity, Morbid (Phase 4)
Only Child (Phase 4)
Opioid-Related Disorders (Phase 4)
Osteoarthritis (Phase 4)
Osteoarthritis, Hip (Phase 4)
Oxidative Stress (Phase 4)
Oxygen (Phase 4)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Palonosetron (Phase 4)
Pancreatic Diseases (Phase 4)
Personal Satisfaction (Phase 4)
Pharmacokinetics (Phase 4)
Pharmacology (Phase 4)
Pharyngeal Diseases (Phase 4)
Pneumonia (Phase 4)
Polyps (Phase 4)
Postoperative Cognitive Complications (Phase 4)
Postoperative Complications (Phase 4)
Postoperative Nausea and Vomiting (Phase 4)
Pre-Eclampsia (Phase 4)
Pregnancy (Phase 3)
Pregnancy Complications (Phase 4)
Psychological Distress (Phase 1)
Remifentanil (Phase 4)
Respiration (Phase 1/Phase 2)
Respiration, Artificial (Phase 4)
Respiratory Distress Syndrome (Phase 4)
Respiratory Distress Syndrome, Newborn (Phase 4)
Respiratory Insufficiency (Phase 4)
Respiratory Tract Infections (Phase 4)
Sclerosis (Phase 4)
Scoliosis (Phase 2)
Sinusitis (Phase 4)
Sleep Apnea, Obstructive (Phase 4)
Sleep Apnea Syndromes (Phase 4)
Spinal Injuries (Phase 4)
Spinal Puncture (Phase 3)
Spinal Stenosis (Phase 4)
Sternotomy (Phase 4)
Stroke (Phase 3)
Suburethral Slings (Phase 3)
Sufentanil (Phase 4)
Supratentorial Neoplasms (Phase 4)
Surgical Procedures, Operative (Phase 4)
Swallows (Phase 4)
Tachycardia (Phase 4)
Thoracic Surgery (Phase 4)
Thyroidectomy (Phase 4)
Thyroid Gland (Phase 4)
Tonsillectomy (Phase 4)
Tooth Extraction (Phase 4)
Tuberculosis (Phase 4)
Urination Disorders (Phase 4)
Venous Cutdown (Phase 4)
Ventilation (Phase 1/Phase 2)
Ventilator Weaning (Phase 2)
Ventricular Dysfunction (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
